Botulinum neurotoxin treatment in children with cerebral palsy: A population-based study in Norway

Elkamil, Areej Ibrahim; Andersen, Guro L.; Skranes, Jon; Lamvik, Torarin; Vik, Torstein

doi:10.1016/j.ejpn.2012.01.008

Cited by 18 publications

(16 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The negative odds of BoNT-A treatment in children with IQ≤85 confirm the results obtained in a Norwegian register-based study, 13 in which children with cognitive impairment received BoNT-A treatment less frequently. Increased awareness of appropriate treatment of children with both CP and cognitive impairment is much needed.…”

Section: Discussionsupporting

confidence: 82%

Impact of child and family characteristics on cerebral palsy treatment

Rackauskaite

Uldall

Bech

et al. 2015

Develop Med Child Neuro

View full text Add to dashboard Cite

Aim The aim of the study was to describe the relationship between the child's and family's characteristics and the most common treatment modalities in a national population‐based sample of 8‐ to 15‐year‐old children with cerebral palsy. Method A cross‐sectional study, based on the Danish Cerebral Palsy Registry. The parents of 462 children answered a questionnaire about their child's treatment and the family's characteristics (living with a single parent, having siblings, living in a city, parental education level). Descriptive and logistic regression analyses were performed for every treatment modality, stratified by Gross Motor Function Classification System (GMFCS) level. Results An IQ below 85 was associated with weekly therapy in GMFCS level I (adjusted odds ratio [ORadj] 2.5 [CI 1.1–5.7]) and the use of oral spasmolytics in GMFCS levels III to V (ORadj 3.1 [CI 1.3–7.4]). Older children in GMFCS levels III to V used daily orthoses less frequently (ORadj 0.7 [CI 0.6–0.9] per year). Of all of the family characteristics studied, only the parents' education level had significant associations with more than one treatment modality. Interpretation A child's cognitive function showed an impact on treatment of the motor impairment in children 8 to 15 years of age with cerebral palsy. Parental education level may influence the choice of treatment.

show abstract

Section: Discussionsupporting

confidence: 82%

Impact of child and family characteristics on cerebral palsy treatment

Rackauskaite

Uldall

Bech

et al. 2015

Develop Med Child Neuro

View full text Add to dashboard Cite

show abstract

“…CP assessment tools [60–69], issues related to quality of life, pain, school function and stress [70–79] and motor function [80–90]. Other studies focused on the use of MRI and imaging [91–95], genetics [96,97], intervention [98–100], CP registry issues [101,102], prediction of function [103] and subject matter relevant to CP including goal writing and attainment [104]. …”

Section: Resultsmentioning

confidence: 99%

Systematic Review of Cerebral Palsy Registries/Surveillance Groups: Relationships between Registry Characteristics and Knowledge Dissemination

Hurley

Sukal-Moulton

Gaebler‐Spira

et al. 2015

Int J Phys Med Rehabil

View full text Add to dashboard Cite

The aims of this study were to provide a comprehensive summary of the body of research disseminated by Cerebral Palsy (CP) registries and surveillance programs from January 2009 through May 2014 in order to describe the influence their results have on our overall understanding of CP. Secondly, registries/surveillance programs and the work they produced were evaluated and grouped using standardized definitions and classification systems.MethodA systematic review search in PubMed, CINAH and Embase for original articles published from 1 January 2009 to 20 May 2014 originating from or supported by population based CP registries and surveillance programs or population based national registries including CP were included. Articles were grouped by 2009 World CP Registry Congress aim, registry/surveillance program classification, geographical region, and the International Classification of Function, Disability and Health (ICF) domain. Registry variables were assessed using the ICF-CY classification.ResultsLiterature searches returned 177 articles meeting inclusion criteria. The majority (69%) of registry/surveillance program productivity was related to contributions as a Resource for CP Research. Prevention (23%) and Surveillance (22%) articles were other areas of achievement, but fewer articles were published in the areas of Planning (17%) and Raising the Profile of CP (2%). There was a range of registry/surveillance program classifications contributing to this productivity, and representation from multiple areas of the globe, although most of the articles originated in Europe, Australia, and Canada. The domains of the ICF that were primarily covered included body structures and function at the early stages of life. Encouragingly, a variety of CP registry/surveillance program initiatives included additional ICF domains of participation and environmental and personal factors.InterpretationCP registries and surveillance programs, including novel non-traditional ones, have significantly contributed to the understanding of how CP affects individuals, families and society. Moving forward, the global CP registry/surveillance program community should continue to strive for uniformity in CP definitions, variables collected and consistency with international initiatives like the ICF so that databases can be consolidated for research use. Adaptation to new technologies can improve access, reduce cost and facilitate information transfer between registrants, researchers and registries/surveillance programs. Finally, increased efforts in documenting variables of individuals with CP into adulthood should be made in order to expand our understanding of CP across the lifespan.

show abstract

“…As the authors acknowledge, both rectus femoris and iliopsoas muscles fire during the performance of the Duncan-Ely test and this may have had an impact on the performance accuracy of the test when compared to three-dimensional gait parameters in swing. 6 Nevertheless, the authors are to be commended for their attention to detail. Now that the Duncan-Ely test can be reliably performed and quantified, the next step is to assess how the knee flexion angle relates to different gait patterns, whether it changes with age, and the extent to which clinicians can rely on it as a predictor of post-operative success after rectus femoris transfer.…”

Section: The Duncan-ely Test: Time For Standardizationmentioning

confidence: 99%

“…The study of Rackauskaite et al 3 joins the few existing ones that have evaluated the patterns of use of neuromotor interventions for children with CP. 2,[4][5][6] This data 2-6 suggest that apart from the type and severity of the motor disability, a neuromotor intervention program for children with CP may be influenced by the child's age and level of cognition as well as sociodemographic factors (e.g. type of insurance, parental education).…”

mentioning

confidence: 99%

Tailoring neuromotor interventions for children with cerebral palsy

Bassan

2015

Develop Med Child Neuro

View full text Add to dashboard Cite

psychosocial functioning. There is also an urgent need to evaluate the impact of specific motor interventions that could be used in clinical practice to enhance the motor outcomes for children who are deaf; this work may prove to have implications that extend well beyond the motor domain. Neuromotor interventions for children with cerebral palsy (CP) consist of a wide variety of strategies, including rehabilitation services, casting, splinting and orthosis, medications for muscle tone management, adaptive equipment/ technology assistance, and neurosurgical and orthopedic surgical procedures. In addition, thanks to the enormous growth of research in CP and neuroplasticity, new avenues of interventions are continuously being introduced for use by the medical community.1 Decision-making in neuromotor intervention programs for individuals with CP historically rely on the experience of clinicians, therapists, and multidisciplinary teams. But evidence-based support is still lacking, despite the increasing use during the past two decades of validated scales for tone and motor function assessment and the emerging data from clinical trials. There are no formal guidelines for optimal neuromotor rehabilitation interventions for affected children.

show abstract

Botulinum neurotoxin treatment in children with cerebral palsy: A population-based study in Norway

Cited by 18 publications

References 34 publications

Impact of child and family characteristics on cerebral palsy treatment

Impact of child and family characteristics on cerebral palsy treatment

Systematic Review of Cerebral Palsy Registries/Surveillance Groups: Relationships between Registry Characteristics and Knowledge Dissemination

Tailoring neuromotor interventions for children with cerebral palsy

Contact Info

Product

Resources

About